Conditions: Pancreatic Acinar Cell Carcinoma; Pancreatic Adenocarcinoma; Pancreatic Adenosquamous Carcinoma; Pancreatic Carcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Squamous Cell Carcinoma; Stage IV Pancreatic Cancer AJCC v8
Interventions: Drug: Nab paclitaxel; Drug: Gemcitabine; Drug: Cisplatin; Procedure: Magnetic Resonance Imaging; Procedure: Computed Tomography; Procedure: Biospecimen Collection
Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI)
Not yet recruiting
Feeds
39849 items (39849 unread) in 74 feeds
Acinar Cell Carcinoma
(940 unread)
Acinic Cell Carcinoma
(353 unread)
Adenoid Cystic Carcinoma
(508 unread)
Adrenal Gland Cancer
(3445 unread)
Ampulla Of Vater
(571 unread)
Anal Cancer
(3170 unread)
Angiosarcoma
(999 unread)
Appendix Cancer
(1255 unread)
Bile Duct Cancer
(5367 unread)
Brain and CNS
(7637 unread)
Carcinoid
(844 unread)
Endocrine/Neuroendocrine
(6579 unread)
Gall Bladder Cancer
(1794 unread)
Hemangioendothelioma
(1742 unread)
Hepatoblastoma
(540 unread)
Pancreas
(596 unread)
Phyllodes
(486 unread)
PMP and Mucinous Tumors
(395 unread)
Rhabdomyosarcoma
(1272 unread)
Sarcoma
(1356 unread)
Trial - Acinar Cell Carcinoma (9 unread)
-
The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer
Posted: November 3rd, 2023, 2:00am GMT
-
Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases
Posted: January 14th, 2022, 3:00pm GMT
Conditions: Pancreatic Cancer; Pancreatic Disease; Microbial Colonization
Intervention: Other: No any intervention
Sponsor: Ruijin Hospital
Recruiting -
Tovorafenib (DAY101) Monotherapy or in Combination With Other Therapies for Patients With Melanoma and Other Solid Tumors
Posted: August 2nd, 2021, 2:00pm GMT
Conditions: Melanoma; Solid Tumor; CRAF Gene Amplification; RAF1 Gene Amplification; BRAF Gene Fusion; BRAF Fusion; CRAF Gene Fusion; CRAF Fusion; RAF1 Gene Fusion; RAF1 Fusion; Thyroid Cancer, Papillary; Spitzoid Melanoma; Pilocytic Astrocytoma; Pilocytic Astrocytoma, Adult; Non Small Cell Lung Cancer; Non-Small Cell Adenocarcinoma; Colorectal Cancer; Pancreatic Acinar Carcinoma; Spitzoid Malignant Melanoma; Bladder Cancer; Bladder Urothelial Carcinoma; MAP Kinase Family Gene Mutation; RAS Mutation; RAF Mutation; MEK Mutation
Interventions: Drug: Tovorafenib; Drug: Pimasertib
Sponsor: Day One Biopharmaceuticals, Inc.
Recruiting -
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells
Posted: November 4th, 2019, 3:00pm GMT
Conditions: Pancreatic Adenocarcinoma Metastatic; BRCA1 Mutation; BRCA2 Mutation; Pancreatic Acinar Cell Carcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Cancer; Metastatic Pancreatic Cancer; Metastatic Pancreatic Ductal Adenocarcinoma; Breast Cancer Metastatic; Breast Cancer Stage IV; Pancreatic Cancer Stage IV; HER2-negative Breast Cancer; HER2 Negative Breast Carcinoma; Adenocarcinoma of the Breast; PALB2 Gene Mutation
Interventions: Drug: Melphalan; Drug: BCNU; Drug: Vitamin B12B; Drug: Vitamin C; Drug: Ethanol; Device: Autologous Hematopoietic Stem Cells
Sponsors: General Oncology, Inc.; Myriad Genetics, Inc.
Recruiting -
Microbial Diversity of Pancreatic Diseases
Posted: January 18th, 2019, 3:00pm GMT
Conditions: Pancreatic Cancer; Pancreatic Disease
Intervention:
Sponsor: Ruijin Hospital
Recruiting -
Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer
Posted: June 30th, 2014, 2:00am GMT
Conditions: Acinar Cell Adenocarcinoma of the Pancreas; Duct Cell Adenocarcinoma of the Pancreas; Stage IV Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride; Drug: Selinexor; Other: Pharmacological Study; Other: Laboratory Biomarker Analysis; Drug: Nab paclitaxel
Sponsors: Mohammed Najeeb Al Hallak
Completed -
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer
Posted: January 28th, 2014, 3:00am GMT
Conditions: Acinar Cell Adenocarcinoma of the Pancreas; Duct Cell Adenocarcinoma of the Pancreas; Stage I Pancreatic Cancer; Stage IIA Pancreatic Cancer; Stage IIB Pancreatic Cancer
Interventions: Drug: oxaliplatin; Drug: leucovorin calcium; Drug: irinotecan hydrochloride; Drug: fluorouracil; Procedure: therapeutic conventional surgery; Other: laboratory biomarker analysis
Sponsors: Yale University; National Cancer Institute (NCI)
Active, not recruiting -
GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery
Posted: April 8th, 2009, 2:00am GMT
Conditions: Adult Solid Neoplasm; Pancreatic Acinar Cell Carcinoma; Pancreatic Ductal Adenocarcinoma; Recurrent Pancreatic Carcinoma; Stage IV Pancreatic Cancer AJCC v6 and v7
Interventions: Other: Diagnostic Laboratory Biomarker Analysis; Drug: Erlotinib Hydrochloride; Drug: Gemcitabine Hydrochloride; Drug: Vismodegib
Sponsors: National Cancer Institute (NCI)
Active, not recruiting -
Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
Posted: April 30th, 2008, 2:00am GMT
Conditions: Locally Advanced Pancreatic Adenocarcinoma; Pancreatic Acinar Cell Carcinoma; Pancreatic Ductal Adenocarcinoma; Stage III Pancreatic Cancer AJCC v6 and v7; Stage IV Pancreatic Cancer AJCC v6 and v7
Interventions: Biological: Falimarev; Biological: Inalimarev; Other: Laboratory Biomarker Analysis; Biological: Sargramostim
Sponsors: National Cancer Institute (NCI)
Active, not recruiting